Protalix BioTherapeutics
PLX
#8648
Rank
A$0.12 B
Marketcap
$1.65
Share price
-4.35%
Change (1 day)
-38.07%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -A$19.77 M

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings (TTM) are -A$19.74 M. In 2023 the company made an earning of A$17.62 M an increase over its 2022 earnings that were of -A$17.8 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$19.77 M-212.12%
2023 A$17.62 M-199.05%
2022 -A$17.8 M-40.38%
2021 -A$29.86 M-732.31%
2020 A$4.72 M-130.53%
2019 -A$15.47 M189.85%
2018 -A$5.34 M-95.29%
2017 -A$0.12 B308.12%
2016 -A$27.77 M-32.37%
2015 -A$41.06 M10.11%
2014 -A$37.29 M-7.59%
2013 -A$40.35 M
2011 -A$46.72 M-19.39%
2010 -A$57.96 M20.87%
2009 -A$47.95 M32.26%
2008 -A$36.26 M-5.46%
2007 -A$38.35 M
2004 -A$0.25 M12.35%
2003 -A$0.23 M-11.1%
2002 -A$0.25 M-57.03%
2001 -A$0.58 M1.03%
2000 -A$0.58 M-53.22%
1999 -A$1.23 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.15 B 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.74 B-3,895.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.82 B 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.24 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel